FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Wright Joseph 2. Issuer Name and Ticker or Trading Symbol MERIT MEDICAL SYSTEMS INC [ MMSI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
PRESIDENT, INTERNATIONAL
(Last)         (First)         (Middle)
1600 WEST MERIT PARKWAY		 3. Date of Earliest Transaction (MM/DD/YYYY)
3/13/2020
(Street)
SOUTH JORDAN, UT 84095
(City)       (State)       (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value  3/13/2020    M    10000  A $13.14  10000  D 
 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy)  $13.14  3/13/2020    M        10000   7/31/2014 (1) 7/31/2020  Common Stock  10000  $0  0  D 
 
Non-qualified stock options (right to buy)  $12.06                  10/4/2015 (2) 10/4/2021  Common Stock  25000    25000  D 
 
Non-qualified stock options (right to buy)  $17.27                  2/13/2016 (3) 2/13/2022  Common Stock  10000    10000  D 
 
Non-qualified stock options (right to buy)  $16.05                  1/28/2017 (4) 1/28/2023  Common Stock  20000    20000  D 
 
Non-qualified stock options (right to buy)  $28.20                  4/14/2018 (5) 4/14/2024  Common Stock  25000    25000  D 
 
Non-qualified stock options (right to buy)  $44.80                  3/2/2019 (6) 3/2/2025  Common Stock  25000    25000  D 
 
Non-qualified stock options (right to buy)  $55.73                  3/1/2020 (7) 3/1/2026  Common Stock  30000    30000  D 
 
Non-qualified stock options (right to buy)  $37.71                  2/26/2021 (8) 2/26/2027  Common Stock  16722    16722  D 
 
Performance Stock Units   (9)                 3/15/2021 (10) 3/15/2023 (10) Common Stock  7955 (11)   7955  D 
 

Explanation of Responses:
(1)  Becomes exercisable in equal annual installments of 20% commencing on 07/31/2014.
(2)  Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
(3)  Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
(4)  Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
(5)  Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
(6)  Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
(7)  Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
(8)  Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
(9)  Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria.
(10)  If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement.
(11)  On February 26, 2020, the reporting person was awarded a target number of performance share units (''PSUs'') pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Wright Joseph
1600 WEST MERIT PARKWAY
SOUTH JORDAN, UT 84095

PRESIDENT, INTERNATIONAL

Signatures
/s/ Brian G. Lloyd, Attorney-in-Fact 3/17/2020
**Signature of Reporting Person Date